Live Breaking News & Updates on Denisa Wagner

Stay updated with breaking news from Denisa wagner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Jubilant Therapeutics Announces Research Collaboration with Boston Children's Hospital, Harvard Medical School, to Evaluate PAD4 Inhibitors in Autoimmune/Inflammation Disease Models


(1)
BEDMINSTER, N.J., Feb. 25, 2021 /PRNewswire/ Jubilant Therapeutics Inc., a biopharmaceutical company advancing small molecule modulators to address unmet medical needs in oncology and autoimmune diseases, today announced a collaboration with Boston Children s Hospital (https://wistar.org/) to evaluate peptidyl arginine deiminase 4 (PAD4) inhibitors under development by Jubilant Therapeutics to explore the modulation of neutrophil extracellular traps (NETosis) in preclinical models of neutrophil regulation and rheumatoid arthritis (RA).
PAD4 is an enzyme that converts arginine to citrulline in histones and is highly expressed in neutrophils. Histone citrullination has been implicated in the formation of NETs which is believed to contribute to pro-inflammation and disease progression in many autoimmune disorders including RA, fibrosis, lupus and ARDS. ....

United States , Kostenloser Wertpapierhandel , Syed Kazmi , Denisa Wagner , Harvard Medical School , Jubilant Therapeutics Inc , Jubilant Life Sciences , National Academy Of Medicine , National Academy Of Sciences , Program In Cellular , Prnewswire Jubilant Therapeutics Inc , Therapeutics Inc , Boston Children , Jubilant Therapeutics , Chief Executive Officer , Senior Investigator , Molecular Medicine , Edwin Cohn Professor , Harvard Medical , World Report , National Academy , Hughes Medical Investigators , Jubilant Life Sciences Limited , Medi Cal , Auto Immune , ஒன்றுபட்டது மாநிலங்களில் ,